We hereby confirm that we have uploaded audio recording of the Q4 & FY2025-26 Earnings Call held on May 15, 2026 on the website of the Company.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alivus Life Sciences (formerly Glenmark Life Sciences) has notified stock exchanges that the audio recording of their Q4 & FY2025-26 Earnings Call held on May 15, 2026 has been uploaded to the company website. This is a routine regulatory compliance filing under SEBI Listing Regulations 30 and 46. The filing itself does not contain any financial figures, earnings details, or management commentary—it merely confirms the availability of the earnings call recording for investor access. The actual substantive content of the earnings call is in the audio file, not in this disclosure letter.
This is a procedural disclosure with no direct impact on stock price. It provides transparency by making the earnings call recording publicly accessible, allowing investors who missed the live call to review management commentary and Q&A sessions.